Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05260034 · ClinicalTrials.gov registry record · NA

Minimizing Fall-Related Injury in Older Adults: a Motor Learning Approach

A NA study of Mobility Limitation and Fall Injury, sponsored by University of Kansas Medical Center.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT05260034: Completed NA study of Mobility Limitation and Fall Injury, sponsored by University of Kansas Medical Center.

NCT05260034 is a NA study of Mobility Limitation and Fall Injury that has completed, run by University of Kansas Medical Center. The registered enrollment target is 33 participants, below the 255-participant average among 28 other Mobility Limitation trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05260034, a NA study of Mobility Limitation and Fall Injury, has completed, sponsored by University of Kansas Medical Center.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

Falls are the leading cause of accidental injury and injury-related death among older adults. Despite evidence that falls can be prevented, fall related injuries have not declined over time. Current fall injury prevention techniques targeting mobility and bone strength have merit yet their effectiveness is limited. Indeed, a recent Patient Centered Outcomes Research Institute/National Institute on Aging funded pragmatic trial of individualized multifactorial strategy to prevent serious fall injuries in over 5500 seniors revealed no difference in fall injuries between the intervention and standard care arm. The inconclusive results of the investigation may be due in part to focusing on fall prevention rather than mitigation of fall-related impact acceleration and forces - the "fundamental variables" for injury prevention. A fall-related injury occurs when the body hits the ground with force that is greater than tissue strength. Development of innovative approaches that focus on fundamental variables of injury prevention is needed.

Primary Outcome

The hypothesis is that there will be minimally greater musculoskeletal discomfort in the FAST group that than in the Otago Exercise Program group, but no difference in adverse events. Physical discomfort will be recorded by an 11-point numerical rating scale (ranging from 0, no discomfort to 10, worst imaginable discomfort). Participants will self-report their discomfort, including the physical location and severity on a standardized body map.

Interventions

  • OTHER FAST Program
  • OTHER Otago Exercise Program

Study Locations (1)

Kansas

  • Emma Eells - Kansas City

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2022-07-18
Est. Completion 2024-04-05
Phase NA
University of Kansas Medical Center

408 total trials

What the finished NCT05260034 record still lists

NCT05260034 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 255-participant average among 28 other Mobility Limitation trials with a reported enrollment target (87% lower).

The record links to 3 conditions, with Mobility Limitation appearing as the primary indexed condition, and to 2 interventions - of which FAST Program is the first listed.

NCT05260034 reports a single indexed study location in Kansas.

Frequently Asked Questions

What is clinical trial NCT05260034 about?

NCT05260034 is a clinical study titled "Minimizing Fall-Related Injury in Older Adults: a Motor Learning Approach". Falls are the leading cause of accidental injury and injury-related death among older adults. Despite evidence that falls can be prevented, fall related injuries have not declined over time. Current fall injury prevention techniques targeting mobility and bone strength have merit yet their effective...

What is the current status of trial NCT05260034?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2022-07-18. Estimated completion is 2024-04-05.

What conditions does trial NCT05260034 study?

This clinical trial studies the following conditions: Mobility Limitation, Fall Injury, Fall Patients.

What interventions are being tested in trial NCT05260034?

The interventions under investigation include: FAST Program (OTHER), Otago Exercise Program (OTHER).

Who is sponsoring clinical trial NCT05260034?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05260034 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mobility Limitation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05260034's enrollment target sits among peer trials

33 21st of 28 higher than 8 of 28 other Mobility Limitation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mobility Limitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02861898 · 33 participants · Phase 1

    Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

  • NCT04871607 · 33 participants · Phase 2

    Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

  • NCT05071937 · 33 participants · Phase 2

    ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

  • NCT05168618 · 33 participants · Phase 2

    Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05260034, the US trial registry maintained by the National Library of Medicine. NCT05260034 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.